Loading clinical trials...
Loading clinical trials...
A Study of ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Conditions
Interventions
ABC008
Locations
8
United States
City of Hope
Duarte, California, United States
University of Southern California
Los Angeles, California, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Start Date
September 28, 2022
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2027
Last Updated
October 28, 2024
Lead Sponsor
Abcuro, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions